1. Mo, Jie, Liang, Huifang, Su, Chen, Chen, Jin, Zhang, Bixiang. 2021. DDX3X: structure, physiologic functions and cancer. In Molecular cancer, 20, 38. doi:10.1186/s12943-021-01325-7. https://pubmed.ncbi.nlm.nih.gov/33627125/
2. Samir, Parimal, Kesavardhana, Sannula, Patmore, Deanna M, Gilbertson, Richard J, Kanneganti, Thirumala-Devi. 2019. DDX3X acts as a live-or-die checkpoint in stressed cells by regulating NLRP3 inflammasome. In Nature, 573, 590-594. doi:10.1038/s41586-019-1551-2. https://pubmed.ncbi.nlm.nih.gov/31511697/
3. Yao, Litong, Hao, Qian, Wang, Mozhi, Zhou, Xiang, Xu, Yingying. 2023. KLHL29-mediated DDX3X degradation promotes chemosensitivity by abrogating cell cycle checkpoint in triple-negative breast cancer. In Oncogene, 42, 3514-3528. doi:10.1038/s41388-023-02858-5. https://pubmed.ncbi.nlm.nih.gov/37845393/
4. Snijders Blok, Lot, Madsen, Erik, Juusola, Jane, Katsanis, Nicholas, Kleefstra, Tjitske. 2015. Mutations in DDX3X Are a Common Cause of Unexplained Intellectual Disability with Gender-Specific Effects on Wnt Signaling. In American journal of human genetics, 97, 343-52. doi:10.1016/j.ajhg.2015.07.004. https://pubmed.ncbi.nlm.nih.gov/26235985/